RIPK3 and Hypertension: Cardiovascular burden, defined as the coexistence of ischemic heart disease, congestive heart failure, and hypertension, is closely linked with both AKI and mortality and may influence cell signaling pathways in which TRAIL and RIPK3 are involved.